Press Releases Ypsomed Group

Burgdorf - Ypsomed filed a lawsuit against Sanofi-Aventis in Germany. Ypsomed believes that the SoloStar injection system developed and manufactured by Sanofi-Aventis is in breach of its own patents. Sanofi-Aventis uses the SoloStar pen for administration of its Lantus and Apidra insulin products.

Burgdorf - With effect from 1 July 2007 and at a cost of around EUR 11 million (approx. CHF 18 million), Ypsomed has bought 100% of the shares in Florian Müller Holding GmbH, thus providing nationwide coverage in diabetes direct sales and distribution throughout Germany, with the focus on the care of insulin pump patients.

Burgdorf - Ypsomed Holding AGr ecently applied for a listing on the BX Berne eXchange in addition to the present listing on the SWX Swiss Exchange. The Berne Stock Market Association as the BX Berne eXchange operator has accepted this application. All the registered shares of Ypsomed Holding AG will therefore also be listed on the BX Berne eXchange from 27 June 2007.

Press Releases Ypsomed Group

Burgdorf - Ypsomed AG, Burgdorf, and Adval Tech Holding Ltd, Niederwangen, have signed an agreement on a strategic cooperation in moldmaking. The goal of this agreement is to combine the respective strengths and core competencies of Ypsomed and Adval Tech and exploit them for the economical manufacturing of highquality medtec products.

Press Releases Ypsomed Group

Burgdorf - In business year 2006/07 the Ypsomed Group posted consolidated sales of CHF 277.5 million (-10.7% prior year), returning to profitability as announced in the second half of the year with consolidated net profits of CHF 2.7 million.